ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "diagnosis"

  • Abstract Number: 2673 • 2018 ACR/ARHP Annual Meeting

    Different Risk Profiles for Development of Steroid-Related and Steroid-Unrelated Damage in Early Diagnosed SLE: Results from the Italian Multicenter Early Lupus Project Inception Cohort

    Matteo Piga1, Gian Domenico Sebastiani2, Imma Prevete3, Florenzo Iannone4, Laura Coladonato5, Marcello Govoni6, Alessandra Bortoluzzi7, Marta Mosca8, Chiara Tani8, Andrea Doria9, Luca Iaccarino10, Angela Tincani11, Micaela Fredi12, Fabrizio Conti13, Francesca Spinelli14, Mauro Galeazzi15, Francesca Bellisai16, Anna Zanetti17, Greta Carrara18, Carlo Alberto Scirè19 and Alessandro Mathieu1, 1Unit and Chair of Rheumatology, University Hospital of Cagliari, Cagliari, Italy, 2Rheumatology, San Camillo Forlanini Hospital, Roma, Italy, 3Azienda Ospedaliera San Camillo of Rome, Roma, Italy, 4Reumatologia Universita e Policlinico di Bari, Bari, Italy, 5Reumatologia, Università e Policlinico di Bari, Bari, Italy, 6UOC of Rheumatology, University Hospital S. Anna, Cona Ferrara, Italy, 7Section of Rheumatology, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliera-University Hospital S. Anna, Cona Ferrara, Italy, 8Rheumatology Unit, University of Pisa, Pisa, Italy, 9University and Azienda Ospedaliera of Padova, Padova, Italy, 10Department of Medicine-DIMED, University of Padova, Padova, Italy, 11Department of Clinical and Experimental Sciences, Spedali Civili and University of Brescia, Brescia, Italy, Rheumatology and Clinical Immunology, BRESCIA, Italy, 12Department of Clinical and Experimental Sciences, Spedali Civili and University of Brescia, Brescia, Italy, Rheumatology and Clinical Immunology, Brescia, Italy, 13Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy, 14Dipartimento di Medicina Interna e Specialita` Mediche, Sapienza Universita` di Roma, Roma, Italy, 15Rheumatology, University Hospital of Siena, Siena, Italy, 16UOC di Reumatologia, Azienda Ospedaliera Universitaria Senese, Siena, Italy, 17Italian Society for Rheumatology, Milano, Italy, 18Epidemiology Unit, Italian Society for Rheumatology, Milano, Italy, 19Italian Society for Rheumatology, Milan, Italy

    Background/Purpose:Preventing organ damage is a major challenge in Systemic Lupus Erythematosus (SLE).To evaluate factors associated with development of steroid-related and unrelated  damage in an inception…
  • Abstract Number: 780 • 2018 ACR/ARHP Annual Meeting

    Urine Metabolomic Profile in Lupus Nephritis

    David Herrera Van Oostdam1, Carlos Abud-Mendoza2, Maribel Rodriguez Aguilar3, Rogelio Flores Ramirez3, Mauricio Pierdant Pérez4, Cesar Eduardo Vallín Orozco5 and Marco Ulises Martinez-Martinez6, 1Unidad de Investigaciones Reumatológicas, Hospital Central & Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, Mexico, 2Hospital Central "Dr. Ignacio Morones Prieto", San Luis Potosi, S.L.P., Mexico, 32. Coordinación para la Innovación y Aplicación de la Ciencia y la Tecnología, San Luis Potosí, San Luis Potosi, Mexico, 4Universidad Autónoma de San Luis Potosí, San Luis Potosi, Mexico, 5Rheumatology, Hospital Central "Dr. Ignacio Morones Prieto", San Luis Potosí, Mexico, 6Unidad de Investigaciones Reumatológicas, Faculty of Medicine, Universidad Autónoma de San Luis Potosí and Hospital Central, San Luis Potosí, Mexico

    Background/Purpose: Lupus nephritis (LN) develops in 50-60% of lupus patients. The consequence of this entity is renal failure, that can arise in 10-15% of patients…
  • Abstract Number: 2784 • 2018 ACR/ARHP Annual Meeting

    Multi Modal Imaging Algorithm to Improve the Accuracy for the Diagnosis of Giant Cell Arteritis

    Augustin Lecler1, Thomas Sené2, Herve Picard3, Tifenn Leturcq2, Kevin Zuber3, Frederique Charbonneau1, Catherine Vignal-Clermont4 and Gaelle Clavel2, 1Department of Radiology, Fondation Ophtalmologique A. de Rothschild, Paris, France, 2Internal Medecine, Fondation Ophtalmologique A. de Rothschild, Paris, France, 3Clinical Research Unit, Fondation Ophtalmologique A. de Rothschild, Paris, France, 4Ophtalmology, Fondation Ophtalmologique A. de Rothschild, Paris, France

    Background/Purpose: Giant Cell Arteritis (GCA) is the most common systemic vasculitis in patient over 50 years of age. It is a medical emergency as it…
  • Abstract Number: 793 • 2018 ACR/ARHP Annual Meeting

    Clinical Associations of Anti-U11/U12 (RNPC-3) Autoantibodies in Patients with Systemic Sclerosis

    Lorenzo Beretta1, Michael Mahler2, Chelsea Bentow2, Andrea Seaman2, Fabrece Roup2, Michelle Amio2, Karl Norvell2, Jay Milo2, Susan Encabo2, Janire Perurena3, Maite Sanz3, Alfredo Guillen4, Ana Marín3, Vicent Fonollosa3, Eduardo Callejas3 and Carmen Pilar Simeón4, 1Scleroderma Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy, 2Research and Development, Inova Diagnostics, San Diego, CA, 3Scleroderma Unit, Internal Medicine Department, Vall d’Hebron Hospital, Barcelona, Spain, 4Scleroderma Unit, Internal Medicine Department, Vall d’Hebron Hospital, Barcelona, Spain

    Background/Purpose: Anti-nuclear antibodies (ANA) are present in approximately 90% of sera from systemic sclerosis (SSc) patients and play an important role in the diagnosis and…
  • Abstract Number: 2804 • 2018 ACR/ARHP Annual Meeting

    Identifying Lupus Patients in Electronic Health Records: Development and Validation of Machine Learning Algorithms and Application of Rule-Based Algorithms

    April Jorge1, Victor M. Castro2, April Barnado3, Vivian Gainer2, Chuan Hong4, Tianxi Cai2, Robert Carroll5, Leslie Crofford3, Karen Costenbader6, Katherine P. Liao7, Elizabeth Karlson6 and Candace H. Feldman6, 1Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2Research Information Systems and Computing, Partners Healthcare, Boston, MA, 3Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN, 4Harvard T.H. Chan School of Public Health, Boston, MA, 5Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, 6Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 7Brigham and Women's Hospital, Boston, MA

    Background/Purpose: To utilize electronic health records (EHR) to study SLE, phenotypic algorithms are needed to accurately identify these patients. We aimed to generate an EHR…
  • Abstract Number: 794 • 2018 ACR/ARHP Annual Meeting

    Identification of an Immunodominant Epitope on Rnpc-3 As a Target of Autoantibodies in Patients with Systemic Sclerosis

    Michael Mahler1, Chelsea Bentow1, Jay Milo1, Marie Hudson2,3, Murray Baron3, May Choi4 and Marvin J. Fritzler4, 1Research and Development, Inova Diagnostics, San Diego, CA, 2Division of Rheumatology, Jewish General Hospital, Lady Davis Institute for Medical Research, Montreal, QC, Canada, 3Department of Medicine, McGill University, Montreal, QC, Canada, 4Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

    Background/Purpose: Anti-nuclear antibodies (ANA) are present in approximately 90% of sera from systemic sclerosis (SSc) patients and play an important role in the diagnosis and…
  • Abstract Number: 2828 • 2018 ACR/ARHP Annual Meeting

    Utility of Fecal Calprotectin Levels for the Diagnosis of Inflammatory Bowel Disease in Patients with Spondylorarthritis

    Maria Espinosa1, Consuelo Ramos Giraldez1, Carolina Merino1, Belen Ruiz Antoran2, Jose Campos1, Carmen Barbadillo3, Hilda Godoy3, Belen Agudo4, Yago Gonzalez4, Jose Luis Andreu5 and Jesus Sanz1, 1Rheumatology, H.U. Puerta de Hierro, Madrid, Spain, 2Pharmacology, H.U. Puerta de Hierro, Madrid, Spain, 3H.U. Puerta de Hierro, Madrid, Spain, 4Gastroenterology, H.U. Puerta de Hierro, Madrid, Spain, 5Hospital Universitario Puerta de Hierro, Madrid, Spain

    Background/Purpose: It is estimated that between 5 and 10% of patients with spondyloarthritis (SpA) are associated with inflammatory bowel disease (IBD).The purpose of our study…
  • Abstract Number: 817 • 2018 ACR/ARHP Annual Meeting

    Current Diagnostic Delays in Vasculitis and Factors Associated with Time to Diagnosis

    Antoine G. Sreih1, Dianne Shaw2, Kalen Young3, Cristina Burroughs4, Joyce Kullman5, Kirthi Machireddy6, Carol A. McAlear1, George Casey3 and Peter A. Merkel7, 1Division of Rheumatology, University of Pennsylvania; Perelman School of Medicine, Philadelphia, PA, 2University of North Carolina, Chapel Hill, NC, 3Vasculitis Foundation, Kansas city, MO, 4University of South Florida, Tampa, FL, 5Vasculitis, Vasculitis Foundation, Kansas City, MO, 6University of Pennsylvania; Perelman School of Medicine, Philadelphia, PA, 7Division of Rheumatology, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA

       Background/Purpose: Despite recent advancements in the evaluation and management of vasculitis, patients with vasculitis continue to encounter diagnostic delays. These delays are often associated…
  • Abstract Number: 966 • 2018 ACR/ARHP Annual Meeting

    Central Triage Clinic for Psoriatic Arthritis – Performance of Triage Methods

    Lihi Eder1, Keith Colaco2, Jensen Yeung3, Chandra Farrer4 and Dana Jerome3, 1Women's College Research Institute, University of Toronto, Women's College Hospital, Toronto, ON, Canada, 2Institute of Medical Science, University of Toronto, Toronto, ON, Canada, 3University of Toronto, Women's College Hospital, Toronto, ON, Canada, 4Rheumatology, Women's College Hospital, Toronto, ON, Canada

    Background/Purpose: Accurate triage methods for patients with psoriasis who have musculoskeletal symptoms could lead to earlier access to rheumatology care for patients with psoriatic arthritis…
  • Abstract Number: 1049 • 2018 ACR/ARHP Annual Meeting

    Optical Biomarkers for the Early Diagnosis of Osteoarthritis

    Paula Casal Beiroa1,2, Elena F. Burguera2,3,4, Tamara Hermida-Gómez2,3,4, Noa Goyanes5, Natividad Oreiro4,6, Pío González7, Francisco J Blanco8 and Joana Magalhaes2,4,9, 1Unidad de Medicina Regenerativa. Grupo de Investigación en Reumatología (GIR), Instituto de Investigación Biomédica de A Coruña (INIBIC). CHUAC. SERGAS., A Coruña, Spain, 2Centro de Investigaciones Científicas Avanzadas (CICA), Universidad de A Coruña (UDC)., a coruña, Spain, 3Unidad de Medicina Regenerativa, Grupo de Investigación en Reumatología, Agrupación Estratégica CICA-INIBIC, Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade de A Coruña (UDC), A Coruña, Spain, 4Centro de Investigación Biomédica en Red (CIBER), madrid, Spain, 5Centro de Investigaciones Científicas Avanzadas (CICA), Universidad de A Coruña (UDC)., A Coruña, Spain, 6Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña. España, A Coruna, Spain, 7Grupo de Nuevos Materiales. Departamento de Física Aplicada. Universidad de Vigo., Vigo, Spain, 8Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC). Sergas. Universidade de A Coruña (UDC), A Coruña, Spain, 9Unidad de Medicina Regenerativa. Grupo de Investigación en Reumatología (GIR), Instituto de Investigación Biomédica de A Coruña (INIBIC). CHUAC. SERGAS., a coruña, Spain

    Background/Purpose: Osteoarthritis (OA) is a rheumatic disease characterized by articular cartilage degradation. On its early stages, OA is asymptomatic and its current gold-standard diagnosis (X-Rays),…
  • Abstract Number: 1236 • 2018 ACR/ARHP Annual Meeting

    Peripheral-Blood B-Cell Subset Disturbances in Whipple’s Disease

    Maelle Le Goff1, Divi Cornec2, Dewi Guellec1, Thierry Marhadour1, Valérie Devauchelle-Pensec1, Sandrine Jousse-Joulin1, Marion Herbette1, Jean-Michel Cauvin3, Clara Le Guillou3, Yves Renaudineau4, Jacques-Olivier Pers5 and Alain Saraux1, 1Rheumatology, CHU Brest, Brest, France, 2Rheumatology and UMR1227, Lymphocytes B et Autoimmunité, CHU Brest, Brest, France, 3CDC, CHU Brest, Brest, France, 4U1227, Université de Brest, inserm, Labex IGO, CHU de brest, Brest, France, 5U1227, Université de Brest, Inserm, Labex IGO, CHU de Brest, Brest, France

    Background/Purpose: Whipple’s disease (WD) is a rare, systemic, disease caused by the intracellular Gram-positive bacterium Tropheryma whipplei (TW). This ubiquitous commensal organism is transmitted among…
  • Abstract Number: 1442 • 2018 ACR/ARHP Annual Meeting

    Differential Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry and a Universal Metabolome Standard Reveals a Metabolome Profile with Consistent Accuracy for Rheumatoid Arthritis

    Walter P. Maksymowych1, Xiaohang Wang2, Joel Paschke1, Rana Dadashova1, Edna Hutchings1 and Liang Li2, 1CaRE Arthritis, Edmonton, AB, Canada, 2Chemistry, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Early diagnosis of rheumatoid arthritis (RA) is hampered by suboptimal accuracy of currently available serological biomarkers. Recent advancements in metabolomic profiling include dansylation liquid…
  • Abstract Number: 1444 • 2018 ACR/ARHP Annual Meeting

    Optimization of Ultrasonographic Examination for the Diagnosis of Erosive Rheumatoid Arthritis Versus Erosive Osteoarthritis with Radiography Considered As Gold Standard

    Camille Roux1, Frédérique Gandjbakhch2, Audrey Pierreisnard3, Marion Couderc4, Cédric Lukas5, Racha Masri1, Jean-Philippe Sommier1, Isabelle Clerc-Urmès6, Cedric Baumann7, Isabelle Chary-Valckenaere8 and Damien Loeuille1, 1Rheumatology, CHRU Nancy, Vandoeuvre les Nancy, France, 2UPMC University Paris 06, Pitié-Salpétrière Hospital, Paris, France, 3APHP, Paris, France, 4Rheumatology, CHU Gabriel Montpied, Clermont-Ferrand, France, 5Rheumatology, CHU Lapeyronie and EA2415, Montpellier University, University of Montpellier, France, 6CHRU Nancy, Nancy, France, 7CHRU Nancy, Vandoeuvre les Nancy, France, 8Rheumatology, CHRU Nancy, Vandoeuvres les Nancy, France

    Background/Purpose: Rheumatoid arthritis (RA) is the most prevalent chronic inflammatory joint disease (1,2) responsible for structural damage. Radiography (RX) is considered as the gold standard…
  • Abstract Number: 1508 • 2017 ACR/ARHP Annual Meeting

    Validation of Self-Reported Inflammatory Back Pain Score Compared to Rheumatology Consultation in University Students

    Nelly Ziade1, Fouad Fayad1 and Lea el-Khoury2, 1Rheumatology, Hotel Dieu de France Hospital and Saint Joseph University, Beirut, Lebanon, 2Saint-Joseph University, Beirut, Lebanon

    Validation of self-reported inflammatory back pain score compared to rheumatology consultation in university students Background/Purpose: Low Back Pain (LBP) is a major public health problem affecting…
  • Abstract Number: 1513 • 2017 ACR/ARHP Annual Meeting

    Clinical Characteristics and Peripheral Joint Involvement at the Time of Diagnosis of Non-Radiographic Axial Spondyloarthritis Patients in the United States and Europe

    Atul A. Deodhar1, Theresa Hunter2, David Sandoval Calderon3, Steve Lobosco4, Rachel Moon4 and Gary Milligan5, 1Oregon Health & Science University, Portland, OR, 2Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Indianapolis, IN, 3Eli Lilly and Company, Indianapolis, IN, 4Adelphi Real World, Macclesfield, United Kingdom, 5Adelphi Real World, Macclesfield,, United Kingdom

    Background/Purpose: Timely identification of nr-axSpA may lead to earlier intervention to reduce symptoms, improve function, and reduce disease burden. The purpose of this study was…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology